A sub-analysis of previous clinical trial (1) conducted with the EHO-85 hydrogel in the treatment of patients with pressure ulcers, venous ulcers or diabetic foot has recently been published in the journal Pharmaceutics (2). On this occasion, the aim was to analyse the ability of the EHO-85 hydrogel to accelerate wound healing [...]
A novel mode of action to promote antibiotic-sparing approach to Recurrent UTIs: Questions and Answers on Clinical Practice1 Consultations for recurrent urinary tract infections (rUTIs) in everyday clinical practice range from 1% to 6% of all medical visits with high social and personal associated costs, such as prescriptions, hospital expenses, [...]
The newer antidiarrheal agents include the mucoprotectants gelatin tannate and xyloglucan. Both were able to attenuate cholera toxin-induced intra-loop water secretion in an experimental study in rats. This supports previous evidence that their mechanism of mucosal protection is closely related to their chemical structures, and involves the ability to form [...]
Let’s celebrate 2022 with a new paper on Utipro® Plus and Utipro® Plus AF!! We are pleased to announce the publication of a meta-analysis in which the benefit of the combination of a mucoprotectant (xyloglucan or an equivalent substance), hibiscus and propolis in the management of uncomplicated urinary tract infections [...]
You may know that Noventure is a Spanish company from Barcelona, part of Ferrer, specialized in medical devices & innovative food supplements. But… who are we in the team, what do we actually do and most importantly… how do we do it❓ Follow us on LinkedIn to find out all the [...]
After the publication of the first paper in which the significant antioxidant activity of Olea europaea leaf extract (OELE) was observed and assessed, we are happy to announce the second publication related to the hydrogel (EHO-85) based on OELE, indicated for the healing of wounds of full and partial thickness. In this study [...]
The first clinical evidence related to an hydrogel based on Olea europaea leaf extract (EHO‐85) indicated for the healing of wounds of full and partial thickness has been published in the Journal of Clinical Medicine. The published article refers to an 8‐week, multicentre, randomized clinical trial designed to demonstrate the accelerating effect on wound healing of the [...]
Several recent studies showed that, despite the overall percentage of bacterial co-infection among COVID-19 patients was low, the use of antibiotic was high. This motivated a team of urologists led by Prof. Tommaso Cai, from the Department of Urology, Santa Chiara Regional Hospital, to discuss the role of managing urinary [...]
We are happy to announce the publication in Pharmaceutics of the first paper related to our hydrogel based on Olea europaea leaf extract (OELE) indicated for the healing of wounds of full and partial thickness. The publication is based on a study that has been designed and carried out by several authors who come from different areas of basic [...]
Acquisition allows Noventure to maintain focus on medical devices and grow therapeutic areas in which it operates Medical devices contain Olea Europaea leaf extract, showing healing properties for ulcers and skin wounds Innovative products are CE marked and available for licensing worldwide Barcelona, Spain, April 19, 2021 – Noventure, specialized in licensing [...]